Dongbang Medical Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Apr '26 Apr 2, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Market Capitalization	137,327	162,252	-	-	-
Enterprise Value	139,431	166,320	-	-	-
Last Close Price	6560.00	7810.00	-	-	-
PE Ratio	11.63	13.86	-	-	-
Forward PE	5.94	7.99	-	-	-
PS Ratio	1.21	1.43	-	-	-
PB Ratio	1.10	1.30	-	-	-
P/TBV Ratio	1.15	1.36	-	-	-
P/OCF Ratio	11.42	13.50	-	-	-
EV/Sales Ratio	1.23	1.47	-	-	-
EV/EBITDA Ratio	5.99	7.15	-	-	-
EV/EBIT Ratio	8.58	10.23	-	-	-
Debt / Equity Ratio	0.27	0.27	0.54	0.59	0.81
Debt / EBITDA Ratio	1.43	1.43	2.01	1.41	3.18
Debt / FCF Ratio	-	-	8.03	17.64	7.86
Net Debt / Equity Ratio	0.00	0.00	0.33	0.29	0.36
Net Debt / EBITDA Ratio	-0.01	-0.01	1.22	0.68	1.43
Net Debt / FCF Ratio	0.13	0.13	4.90	8.53	3.53
Asset Turnover	0.67	0.67	0.79	0.79	-
Inventory Turnover	2.12	2.12	2.29	2.22	-
Quick Ratio	1.19	1.19	0.73	0.68	0.61
Current Ratio	2.12	2.12	1.44	1.36	1.13
Return on Equity (ROE)	11.11%	11.11%	4.64%	20.18%	-
Return on Assets (ROA)	6.03%	6.03%	7.24%	9.31%	-
Return on Invested Capital (ROIC)	10.50%	11.21%	8.07%	21.00%	5.67%
Return on Capital Employed (ROCE)	11.50%	11.50%	15.50%	24.50%	9.20%
Earnings Yield	8.52%	7.21%	-	-	-
FCF Yield	-1.82%	-1.54%	-	-	-
Buyback Yield / Dilution	-28.29%	-28.29%	7.51%	-17.90%	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.